TrialThe lancet. Diabetes & endocrinology2019

Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.

Ildiko Lingvay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.